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Abstract 
Background: Countries of the greater Mekong subregion have made a transition from malaria control to an aim for 
falciparum and vivax malaria elimination. The elimination of falciparum malaria will have to be achieved against a 
background of increasing artemisinin and multi‑drug resistance. This ambitious goal requires an operational research 
(OR) agenda that addresses the dynamic challenges encountered on the path to elimination, which will need to be 
flexible and developed in close relation with the cambodian national programme for parasitology, entomology and 
malaria control (CNM). In Cambodia, a number of meetings with stakeholders were convened by the CNM and emer‑
gency response to artemisinin resistance (ERAR) hub, producing an initial list of priority OR topics. The process and 
outcome of these meetings are described, which could serve as a template for other countries in the region.
Methods: A landscaping exercise was conducted to gather all past, on‑going and planned malaria focussed OR 
activities conducted by the cambodian research consortium in Cambodia and categorized according to research 
theme. The six themes included (1) malaria epidemiology, surveillance and response, (2) malaria case management, 
(3) malaria vector control, (4) malaria behavioural issues, (5) malaria clinical studies, and (6) other vector‑borne dis‑
eases (dengue, neglected tropical diseases, soil‑transmitted helminths). The different themes were discussed in small 
focus groups, which made an initial prioritization list which was then presented to a plenary group for further discus‑
sion. This produced a list of research questions ranked according to priority.
Results: OR priorities produced by the thematic groups were discussed in the plenary meeting and given a priority 
score by group voting. A list of 17 OR questions were developed, finalized and listed, which included questions on 
surveillance, active case detection and treatment efficacy.
Conclusion: This paper describes ERAR’s work on supporting Cambodia’s transition to malaria elimination by identi‑
fying national operational research priorities. ERAR has initiated and currently plays a critical role in the development 
of country specific research agendas for malaria elimination. The first example of this has been the described exercise 
in Cambodia, which could serve a template for setting OR priorities in the wider region.
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Background
In the past decade, large-scale funding and the devel-
opment of improved technologies and strategies have 
resulted in impressive improvements in malaria control, 
and this in turn has led to renewed attempts at malaria 
elimination in a number of countries [1]. All countries in 
the greater Mekong sub-region (GMS) have set national 
malaria elimination goals. At the same time, global and 
regional strategic support for these efforts is growing, 
evidenced by the World Health Organization’s (WHO) 
new Global Technical Strategy for Malaria 2016–2030 
[2] and a strategy for malaria elimination in the Greater 
Mekong sub-region 2015–2030 [3], as well as the newly 
defined Asia Pacific regional elimination goal of 2030 [4].
In Cambodia, there has been a marked decrease of 
81 % in annual cases due to Plasmodium falciparum since 
2009 [5]. Cambodia is now moving towards elimination, 
and aims to move towards pre-elimination of malaria 
with special efforts to (1) contain artemisinin-resistant 
P. falciparum malaria by 2015, (2) to achieve elimina-
tion of falciparum malaria (and thus malaria deaths) by 
2020, and (3) to achieve a phased elimination of all forms 
of malaria in Cambodia by 2025 [6]. To achieve these 
elimination targets, Cambodia must increase and accel-
erate operational research (OR) activities around malaria 
elimination.
As countries approach elimination status, there is a real 
and documented risk of resurgence [7] which has been 
linked to the weakening of national programmes and 
accompanying resource constraints when malaria disap-
pears as a public health threat [7]. Cambodia faces the 
additional important challenges of artemisinin resistance 
(ART-R) and multi-drug resistant falciparum malaria 
causing high treatment failure, which threatens to ham-
per the progress made in reducing the number of malaria 
cases. In addition, Cambodia has highly porous borders 
[8] and highly mobile populations [9], increasing the risk 
of imported cases from neighbouring malaria endemic 
countries. Documented evidence of poor anti-malarial 
drug quality also risks further impeding the development 
of resistance by increasing drug pressure on partner 
drugs [10, 11].
The emergency response to artemisinin resistance 
in the greater Mekong sub-region (ERAR) is a regional 
framework for action that was launched by the World 
Health Organization (WHO) in April 2013, with an 
aim to scale up malaria intervention and containment 
efforts in the Greater Mekong sub-region (GMS) [12]. 
This framework ensures both a coordinated response 
to ART-R in the region and continued motivation for 
stakeholders and national programmes to continue 
their efforts to achieve malaria elimination, whilst also 
contributing to the development of a regional OR agenda 
for elimination in the specific context described above.
OR can be defined as: ‘the search for knowledge on inter-
ventions, strategies or tools that can enhance the quality, 
effectiveness, or coverage of programmes in which research 
is being done’, hence OR should contribute to either influ-
encing policy change or improving performance at a dis-
trict, national or international scale [13]. OR activities 
are encouraged by donors and development partners in 
order to tackle obstacles relating to scaling up projects; in 
particular the global fund to fight aids, tuberculosis and 
malaria (GFATM) recommends their projects to spend 
5–10  % of their budget on monitoring and evaluation, 
including OR [14]. Engaging stakeholders and policy and 
decision-makers when developing research questions can 
help increase acceptance, collaboration and ownership of 
activities by ensuring interaction between stakeholders 
on the research and decision-making sides, and encour-
aging mutual trust and learning [15–19].
The WHO has emphasized the importance of OR 
as more countries move towards malaria elimination, 
and setting research priorities can help orient research 
towards the specific needs [20–25]. The Global Plan for 
Artemisinin Resistance Containment (GPARC), pub-
lished in 2010, recommends investing in ART-R related 
research [24] and Action 8 in the ERAR Framework for 
Action 2013–2015 stipulates the need to “Fast track pri-
ority research and refine tools for containment and elimi-
nation”. The framework highlights the importance of 
sharing and disseminating information as well as lessons 
learned with stakeholders both nationally and regionally 
[25].
To date, two meetings have been conducted on the pri-
oritization of OR at a global and regional scale. At the 
WHO/GMP meeting in October 2013 in Geneva, Swit-
zerland, participants prioritized 17 OR questions from 
an overall 45 questions [1] and at the SEARO/WPRO 
conference in December 2013 in Bangkok, Thailand, this 
priority list was reduced to six questions relevant to the 
GMS countries and a further five tentative OR questions 
for Cambodia specifically [26].
Cambodia has recognized the importance of OR in 
conjunction with elimination activities, and in October 
2010 a regional meeting funded by USAID was organ-
ized around identifying and prioritizing key OR areas 
including prevention, case management, Plasmodium 
vivax and glucose-6-phosphate dehydrogenase deficiency 
(G6PD deficiency), vulnerable populations, Monitor-
ing and Evaluation and surveillance, health systems and 
the private sector [27]. These research areas were high-
lighted by national programmes in the Mekong as critical 
to help countries move from control to elimination [27]. 
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Following this, the Cambodian national programme for 
parasitology, entomology and malaria control (CNM) 
established the CNM Task Force for Research in Janu-
ary 2014 to develop and review the institutional research 
agenda for CNM, review and approve research propos-
als and studies prior to submission to funding agencies 
and oversee progress made on CNM’s research studies, 
evaluations and surveys. To accelerate research further, 
the time to obtain ethical approval for research, and the 
development of the OR agenda, CNM’s Sub technical 
working group ratified the establishment of the Cambo-
dia research consortium (CRC) on 09 May 2014 [28].
The Ministry of Health of Cambodia, with technical 
assistance and support by WHO-ERAR, held a two-day 
workshop on the 3–4 June 2014 with the members of the 
CRC, which includes various national and international 
partners, stakeholders, NGOs and members of the Cam-
bodian provincial health teams.
The objectives of the workshops were to:
1. Review the malaria OR landscape;
2. Identify operational challenges, bottlenecks and 
priority research questions in the transition from 
malaria control towards elimination; and
3. Reach agreement among the meeting participants on 
the next steps, roles and responsibilities in line with 
the CNM’s requirements.
This paper discusses the methods used by the Minis-
try of Health/Government of Cambodia and the ERAR 
framework to ensure effective and efficient use of OR to 
address its evolving malaria and other vector borne dis-
ease issues. Here it is described the process used to (1) 
prioritize research questions related to malaria elimi-
nation in the Cambodian context; and (2) address pro-
gramme gaps.
Methods
In order to prioritize OR questions we reviewed examples 
from other international and regional efforts [29–35]. 
Of particular use were the Planning Meeting for Opera-
tional Research on Malaria Elimination organized by the 
WHO/GMP and held in 17–18 October 2013 in Geneva, 
Switzerland [1], as well as the GMS regional meeting 
organized by SEARO and WPRO: ‘Informal consultation 
on operational research to support accelerating malaria 
elimination in the context of artemisinin resistant fal-
ciparum malaria in the Greater Mekong Sub region’ in 
December 2013, Bangkok, Thailand [26].
Prior to the workshop on the 3–4 June 2014 a con-
cept note was developed including a brief literature 
review, and a partner inventory form was completed by 
all research partners. The partner research inventory list 
2014 is a comprehensive database of malaria research 
studies, which are recently finished, under implemen-
tation or are planned in the immediate future by part-
ners in Cambodia. Every research study was classified 
according to the type of study and study theme. After 
the workshop, additional information was gathered via 
face-to-face interviews and follow-up emails with rele-
vant stakeholders. During this process, participants from 
MoH (including central and provincial levels), NGOs, 
academics, the private sector, donors and policy makers 
were involved and actively participated in the workshops.
To identify priority malaria OR questions a three-step 
process was used, based on the aforementioned meeting 
in October 2013 in Geneva:
1. Participants were allocated to working groups under 
one of the six thematic areas (1) malaria epidemiol-
ogy, surveillance and response, (2) malaria case man-
agement, (3) control of malaria vectors, (4) malaria 
behavioural issues, (5) malaria clinical studies and (6) 
other vector borne diseases [dengue, neglected tropi-
cal diseases (NTDs) and soil-transmitted helminths 
(STH)].
2. Participants were asked to develop a short list of pri-
oritized questions in each theme;
3. Scoring across themes according to agreed prioritiza-
tion criteria; and
4. Consensus on final priority list.
In order to understand the success and utility of the 
prioritization process, and allow qualitative evaluation 
to inform both Cambodia’s next steps and recommenda-
tions to other countries facing similar challenges regard-
ing the management of OR, a second workshop was 
conducted using participatory approaches embedded in 
the sub-technical Working Group Meeting held on 17th 
September 2014, organized by CNM with support from 
ERAR–GMS.
The objectives of this evaluation were to:
1. Gain participants’ perspectives on the success and 
challenges of the prioritization process;
2. Identify lessons learnt for future use of this approach;
3. Discuss how to translate the outcome of a prioritized 
list of research questions into operation in-country 
with present and new stakeholders; and
4. Identify challenges that remain in supporting the 
translation of research into policy and practice and 
how to address these issues.
Participants were split into the following three groups 
to discuss in-depth one of the following topics linked to 
the objectives:
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1. Comments on the process;
2. How to maintain momentum and follow through on 
priorities; and
3. What else is needed to translate research priorities 
into policy and practice?
Finally, a plenary was held with the group to discuss the 
outcomes and to get their feedback.
Results
List of prioritized questions in each theme
Within the six thematic groups, six to eight participants 
were required to list 10 specific research questions that 
addressed gaps in research, and from this list identify 
three to five questions that were most important. Each 
group then reported on the prioritized questions to ple-
nary, which then worked to refine the questions. As a 
result, a total of 20 research areas were developed across 
the six themes (Table 1).
Rank ordering
Based on the list generated in Step 1, a ranking exercise 
was conducted by all participants present. The facilitators 
used methods and tools developed by John Snow, Inc. 
(JSI) [36] which were modified for the malaria elimina-
tion focus (Table  2). Criteria were agreed by all partici-
pants before start of the further exercise.
Ranking was conducted by individual participants 
voting and an overall score was calculated. With a few 
exceptions, there was a high level of consensus regarding 
the ranking priorities. However, in case of important dif-
ferences in scoring, participants were given an opportu-
nity for further discussion until a consensus was reached. 
This list of shared, agreed priorities is shown in Table 3.
Following the discussions, ‘insecticide resistance’ under 
the umbrella of ‘vector mapping’ was included as a research 
priority. Ranking was not conducted for ‘other vector-
borne diseases’ as most participants were malaria experts, 
though this was still identified as a priority in Step 1.
Table 1 Specific research areas identified, by thematic area
Thematic area Research areas
Malaria epidemiology, surveillance and response Mapping of mobile migrant populations (MMPs) (malaria burden in MMPs; Information on 
MMP status for every case in the MIS; prophylaxis for malaria control in MMP)
Improved case surveillance (case‑based surveillance with GIS (low endemic settings); detailed 
malaria risk maps; Real time cross‑border surveillance to be used by both the countries; fol‑
low up surveillance for directly observed therapy (DOT) adherence)
Malaria case management Asymptomatic cases and active surveillance and treatment
Feasibility of conducting DOTs for malaria cases
Use of microscopy as a primary method of laboratory confirmed diagnosis for malaria and 
establishment of a quality control program
Control of malaria vectors Vector Mapping—Changing environment/Epidemiology/variation across the country requires 
research into vectors (changing biting patters, life‑cycle, species, exo/endophilic, etc.)
Insecticide resistance: research into potential pyrethroid resistance/insecticide efficacy
Bed net research—Good national coverage, but how effective are they, are they protecting 
the most at risk populations (mobile migrant workers); Sleeping behaviour of the net use net 
preference studies (hammocks, texture, colour)
Malaria behavioural issues How Does DOT change behaviour of the patients? Adherence of DOTs
Huge investments in DOTs—are they worth it?
How can we increase participatory village interventions? Active community involvement?
How can we increase the malaria education provided to patients by health facilities/village 
malaria workers (VMW)?
How best to communicate with MMPs/forest goers?
Malaria clinical studies New ACTs drug efficacy, Artesunate + Pyronaridine
First line treatment drug efficacy (Pf, Pv)
Safety of primaquine (G6PD Screening)
Other vector borne diseases (Dengue, NTDs and STHs) Dengue/chikungunya surveillance and estimation of disease burden—lacking in adult and 
private sector
To determine a sustainable, effective and ecologically safe vector control measure for dengue 
control
NTD surveillance and estimation of disease burden—lacking in private sector
NTD surveillance and vector control
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A list of priority questions
In the subsequent plenary meeting, the results of the 
ranking (ranging from high to lower priority) were 
reviewed to obtain consensus on a list of priority topics, 
which were then translated into corresponding research 
questions (Table 4).
Once the workshop was concluded, draft minutes of 
the meeting were circulated to all participants for feed-
back, which included corrections pertaining to the ple-
nary discussions as well as corrections and additions to 
the Partner Research Inventory List 2014. Once all feed-
back had been received, a final version of the meeting 
minutes was circulated.
Discussion
According to ERAR, country-specific ART-R contain-
ment objectives include ‘undertaking basic research and 
OR to ensure evidence-based strategies’. International 
agendas have been set [29–33, 37] and ERAR has initi-
ated and played a critical role in the development of 
country specific agendas for malaria elimination OR. The 
first example of this has been the above described work 
in Cambodia, which has set research and development 
priorities to identify knowledge gaps and tools needed to 
move towards malaria elimination, whilst also comple-
menting existing research agendas.
In order to enable the use of research findings, the 
research capacity in developing countries needs to be 
strengthened to both allow researchers to produce con-
textually relevant research and to ensure local ownership 
[28]. An OR landscaping exercise conducted by WHO 
found few OR projects conducted regionally were led 
by the national malaria programmes, who have intimate 
knowledge of the real situation and the bottlenecks in 
their own programmes [1]. Researchers from low and 
middle income countries are best placed to provide local 
and national policy makers with the evidence required to 
inform decision making in their own nations [28]. Dur-
ing this process in Cambodia, involving participants from 
all different sections in the workshops allowed a wealth 
of information and experiences to be shared and uti-
lized in the decision-making process. This also started 
the process of addressing a challenge identified in the 
landscaping—that not all partners knew of each other’s 
work nor participated in discussing research priorities. It 
enabled fruitful discussions to take place to identify OR 
priorities and concerns as Cambodia transitions towards 
elimination.
The preparation work for the workshop was an impor-
tant part of the process which included meetings with 
key stakeholders from CNM, WHO, NGOs and academ-
ics. Circulating the Partner Research Inventory List 2014 
before the workshop enabled the creation of a transpar-
ent information-sharing platform, and ensured all partic-
ipants started with the same information to inform their 
discussions and decisions at the workshop. It is essential 
Table 4 Operational research topics ranked by scoring criteria
No OR Topic Score
1 How can we increase participatory village interventions in active community involvement such as ACD and treatment? 18
2 How can we increase the quality and effectiveness of malaria education provided to patients by health facilities/VMWs, to improve  
awareness of, and prevention measures against malaria?
17
3 What are the most effective means of improving MMP Surveillance? 16
4 What are the most effective means of improving malaria case surveillance 16
5 Monitoring the efficacy of A + M for the treatment of Pf and Pv malaria cases 16
6 Evaluation of active surveillance and treatment of asymptomatic malaria cases 15
7 How has the epidemiology of vectors changed over the past 10 years? 15
8 How does DOTs change the behaviour of the patients and their adherence to anti‑malarials? 15
9 How safe is primaquine administration in Cambodia, and what is the role of G6PD Screening? 15
10 Monitoring the efficacy of novel ACTs (Artesunate + Pyronaridine) in drug resistant regions of Cambodia 14
11 How effective are LLINs in protecting the most at risk populations (mobile migrant workers), and how does net preference and sleeping 
behaviour affect their use?
13
12 What is the prevalence of dengue and chikungunya in Cambodia? 12
13 How feasible is it to DOTs for malaria cases in Cambodia? 11
14 Is it feasible to use microscopy as a primary method of laboratory confirmed diagnosis for malaria and can a quality control program be 
established?
11
15 Is there a sustainable, effective and ecologically safe alternative to Abate for vector control measure for dengue control? 10
16 How can the capacity of the private sector be improved to incorporate NTD surveillance and the estimation of disease burden? 0
17 What surveillance and vector control methods are needed for NTDs in Cambodia? 0
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that this list is kept updated with the recently developed 
Cambodia Elimination Action Framework for Malaria 
(2016–2020) as well as new and upcoming projects and 
that it remains available to all partners. The advantage 
of following the three-step method for prioritizing OR 
was that participants were able to discuss issues both in 
smaller groups relating to their thematic areas, as well 
as in plenary. The facilitators noted that this allowed 
more engagement by participants, with some partici-
pants feeling more comfortable to talk both in smaller 
groups and in familiar subject areas. The plenary ses-
sions then allowed people to hear the opinions of others 
and, in a Delphi like process, review the priorities across 
all aspects of malaria programmes not just those of their 
particular thematic interest. This allowed the develop-
ment of a joint and shared view of programme needs.
OR questions on ‘drug resistance’ were mentioned a few 
times in the specific research areas identified (Table  1). 
Most participants were familiar with the issue of drug 
resistance and most likely the questions posed in Table 1 
were meant to be in the context of drug resistance. None-
theless, more emphasis is warranted on research around 
this theme, including:
  • surveillance of ART-R malaria (including genetic epi-
demiology) and how to report best and disseminate 
these findings;
  • response dynamics once ART-R has arrived;
  • implementation research around novel treatment 
strategies;
  • community awareness of ART-R malaria;
  • prevention of spread of ART-R malaria; and
  • operational aspects of community engagement 
aspects of mass drug administration.
The idea of a ‘Partnership Agreement’ was discussed; 
the agreement will define the need for research to fit into 
the National Strategic Plan for Malaria Elimination [6], 
the process of sharing of results with the programme as 
a priority outcome of all research, and the importance 
of building national capacity as part of all partners work 
plans. This idea was supported by all. Lessons learnt from 
agreements such as those in sector wide approaches 
(SWAps) may be a useful start for drafting the plan [38]. 
The instrumentality of the Cambodian Research Consor-
tium to facilitate prospective research including foment-
ing dialogue between research projects and the national 
ethics committee for health research (NECHR) was 
widely discussed and welcomed [28].
It was suggested more systematic data collection and 
data conservation with predefined methods for analysis 
should be developed. This could prove to be highly pro-
ductive in providing evidence more rapidly, especially 
given that a close link between research and programmes 
can enable the faster application of new evidence. The 
Regional Artemisinin Initiative (RAI), funded by the 
GFATM, is focussing on enabling a much closer link 
between research and implementation, which implies 
much closer links of research groups (including aca-
demia) and implementers (“learning by doing”); how-
ever, could also have consequences for funding models. 
Learning by doing is strongly suggested in the emergency 
context of rapidly evolving ART-R malaria and provides 
results in a much shorter time frame than in the usual 
cycle of small-scale research projects.
Especially in the context of rapidly evolving multid-
rug resistance-malaria (MDR) malaria, the usual cycle 
of small-scale research project providing us with results 
several years later, will take a long time. More systematic 
data collection and data conservation with predefined 
methods for analysis could prove to be highly produc-
tive in providing evidence more rapidly. The close link 
between research and programme ensures faster applica-
tion of new evidence [39].
Governance architecture for prioritization of research 
themes should structured in more detail; which includes: 
the roles of CNM, WHO, academia, NGOs and other 
stakeholders. This might address the need for flexibility, 
since the circumstances can change quite rapidly over 
time. A central repository of planned, on-going and com-
pleted projects has been completed for 2014. However it 
is suggested that this is updated every year.
The process conducted in the two workshops has 
addressed some of the challenges identified in Fig.  1; 
however most participants recognized that this was not 
enough. A major challenge described in the landscaping 
that has not been fully explored to date, in the Cambo-
dian and many similar settings, is the need for capacity 
development in the design, conduct, analysis and use of 
implementation research. Initiatives like SORT-IT [40] 
which have been successful in developing TB programme 
capacities to meet operational needs, and may be a use-
ful approach for partners in Cambodia and the region to 
consider.
In addition, regional platforms like APMEN offer 
the opportunity for the sharing of protocols and les-
sons learned related to conduct operational research for 
malaria elimination. This sharing of real-life experience is 
invaluable to Cambodia when scarce scientific evidence 
on the topic exists to aid decision-making and can further 
support Cambodia to confidently develop strategies that 
will deliver a malaria-free Asia Pacific by 2030 [41]. Simi-
larly, the Asia Pacific Leaders Malaria Alliance (APLMA), 
which is formed from the Asia Pacific Heads of Govern-
ment, have agreed to the goal of an Asia Pacific free of 
malaria by 2030 and they have developed the Leaders’ 
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Malaria Elimination Roadmap to establish a technically 
robust, strategically coherent and regionally coordinated 
approach to malaria elimination [42].
The malaria eradication scientific alliance (MESA) and 
the MESA-Track enables malaria research project to be 
shared worldwide [43]. Likewise the worldwide antima-
larial resistance network (WWARN) is a collaborative 
platform generating innovative resources and reliable 
evidence to inform the malaria community on the factors 
affecting the efficacy of anti-malarial medicines [44].
As a recommended next step, the CRC should consider 
defining a governance architecture for the prioritization 
of research themes, including the roles of CNM, WHO, 
acadaemia, NGOs and other stakeholders. This will allow 
research topics to be identified and prioritized in an 
organized and timely process. Lastly, the CRC must be 
flexible; in the current environment of ART-R it is likely 
that the malaria epidemiology in the region will change 
rapidly over time.
Conclusions
The need for high quality, useful and operationally 
focussed research to assist programmes in reaching 
global malaria targets has been clearly identified in the 
new strategy for malaria elimination in the Greater 
Mekong sub-region (2015–2030) [3], the global techni-
cal strategy for malaria (GTS) (2016–2030) [2], and the 
second generation Global Malaria Action Plan “Action 
and Investment to defeat Malaria (AIM)—for a malaria-
free world” [45]. The challenge of maximizing the use of 
research to improve quality, coverage, effectiveness and 
efficiency of malaria elimination programmes is shared 
by many countries. The need for the populations whom 
all malaria partners serve to have access to an acceptable, 
affordable, effective malaria service must be reached, and 
even more urgently with the threat of artemisinin and 
insecticide resistance looming.
Finding a way through the complex malaria partner 
landscape, and ensuring country leadership and owner-
ship and reduction of opportunity costs is a priority. The 
Cambodian experience described shows one country’s 
attempt at addressing these gaps. Helping this become a 
reality, and remain the norm will require honesty, integ-
rity and goodwill of all partners and is the responsibility 
of all involved in research and programme management 
in such settings to ensure the achievement of the under-
lying objectives of these initiatives. The Cambodian expe-
rience can potentially become a framework that can be 
used in other countries aiming to transition from malaria 
control to elimination.
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